Scott Mazza, co-founder of Vitality CBD, examines the shifting federal landscape for hemp regulations and the critical need for a permanent regulatory pathway through legislation like the HEMP Act. Writing for WholeFoods Magazine, Mazza details how “total THC” framework changes and synthetic cannabinoid bans threaten industry stability, impacting over 300,000 jobs and consumer access to hemp-derived wellness. His analysis underscores Vitality CBD’s commitment to transparent FDA oversight and high-quality production standards to ensure long-term market maturity and consumer safety.

In this WholeFoods Magazine column, Scott Mazza, co-founder of Vitality CBD, argues that while peer-reviewed research increasingly supports CBD’s potential for anxiety, pain, sleep, and inflammation, inconsistent production standards continue to undermine its medical credibility. Drawing on regulatory data and industry experience, Mazza outlines how contamination, inaccurate labeling, and lack of GMP compliance prevent CBD from being taken seriously by healthcare and policymakers. He calls for nuanced, science-aligned regulation (quality standards, mandatory testing, and federal certification) rather than blanket bans, to move CBD toward evidence-based wellness adoption.

In this WholeFoods Magazine column, Scott Mazza, co-founder of Vitality CBD, examines how the upcoming Farm Bill 2025 could reshape the U.S. hemp and CBD market. Mazza outlines the risks posed by unclear federal guidance, state-by-state enforcement, and proposals such as a “total THC” standard, arguing that these moves threaten responsible operators as much as bad actors. He calls for coordinated, science-based regulation, rather than product bans, to protect consumers, establish quality standards, and support CBD’s transition from novelty product to legitimate wellness category, as published in WholeFoods Magazine.